References
- Al-Assal K, Martinez AC, Torrinhas RS, Cardinelli C, Waitzberg D. Gut microbiota and obesity. Clin Nutr Exp. 2018 Aug;20:60–64. https://doi.org/10.1016/j.yclnex.2018.03.001
- Alhinai EA, Walton GE, Commane DM. The Role of the gut microbiota in colorectal cancer causation. Int J Mol Sci. 2019 Oct; 20(21):5295. https://doi.org/10.3390/ijms20215295
- Brennan CA, Garrett WS. Gut Microbiota, inflammation, and colorectal cancer. Annu Rev Microbiol. 2016 Sep;70:395–411. https://doi.org/10.1146/annurev-micro-102215-095513
- Cheng WY, Wu CY, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut. 2020 Oct;69(10):1867–1876. https://doi.org/10.1136/gutjnl-2020-321153
- Davis CD. The gut microbiome and its role in obesity. Nutr Today. 2016 Jul-Aug;51(4):167–174. https://doi.org/10.1097/NT.0000000000000167
- De Simeis D, Serra S. Actinomycetes: A Never-ending source of bioactive compounds – an overview on antibiotics production. Antibiotics. 2021 Apr;10(5):483. https://doi.org/10.3390/antibiotics10050483
- Dinsdale EA, Edwards RA, Bailey BA, Tuba I, Akhter S, McNair K, Schmieder R, Apkarian N, Creek M, Guan E, et al. Multivariate analysis of functional metagenomes. Front Genet. 2013 Apr;4:41. https://doi.org/10.3389/fgene.2013.00041
- Dorrestein PC, Mazmanian SK, Knight R. Finding the missing links among metabolites, microbes, and the host. Immunity. 2014 Jun;40(6):824–832. https://doi.org/10.1016/j.immuni.2014.05.015
- Ghosh A, Mehta A, Khan AM. Metagenomic analysis and its applications. In: Ranganathan S, Gribskov M, Nakai K, Schönbach C, editors. Encyclopedia of bioinformatics and computational biology. Oxford (UK): Academic Press; 2019. p. 184–193. https://doi.org/10.1016/B978-0-12-809633-8.20178-7
- Kultima JR, Coelho LP, Forslund K, Huerta-Cepas J, Li SS, Driessen M, Voigt AY, Zeller G, Sunagawa S, Bork P. MOCAT2: A metagenomic assembly, annotation and profiling framework. Bioinformatics. 2016 Aug;32(16):2520–2523. https://doi.org/10.1093/bioinformatics/btw183
- Li D, Liu CM, Luo R, Sadakane K, Lam TW. MEGAHIT: An ultrafast single-node solution for large and complex metagenomics assembly via succinct de Bruijn graph. Bioinformatics. 2015 May;31(10): 1674–1676. https://doi.org/10.1093/bioinformatics/btv033
- Li J, Chu R, Wang C, Li Y, Wu B, Wan J. Microbiome characteristics and Bifidobacterium longum in colorectal cancer patients pre- and post-chemotherapy. Transl Cancer Res. 2020 Apr;9(4):2178–2190. https://doi.org/10.21037/tcr.2020.03.33
- Liu J, Luo F, Wen L, Zhao Z, Sun H. Current understanding of microbiomes in cancer metastasis. Cancers. 2023 Mar;15(6):1893. https://doi.org/10.3390/cancers15061893
- Mas-Lloret J, Obón-Santacana M, Ibáñez-Sanz G, Guinó E, Pato ML, Rodriguez-Moranta F, Mata A, García-Rodríguez A, Moreno V, Pimenoff VN. Gut microbiome diversity detected by high-coverage 16S and shotgun sequencing of paired stool and colon sample. Sci Data. 2020 Mar;7(1):92. https://doi.org/10.1038/s41597-020-0427-5
- Moschen AR, Gerner RR, Wang J, Klepsch V, Adolph TE, Reider SJ, Hackl H, Pfister A, Schilling J, Moser PL, et al. Lipocalin 2 protects from inflammation and tumorigenesis associated with gut microbiota alterations. Cell Host Microbe. 2016 Apr;19(4):455–469. https://doi.org/10.1016/j.chom.2016.03.007
- Olano C, Méndez C, Salas JA. Antitumor compounds from marine Actinomycetes. Mar Drugs. 2009 Jun;7(2):210–248. https://doi.org/10.3390/md7020210
- Prudence SMM, Addington E, Castaño-Espriu L, Mark DR, Pintor-Escobar L, Russell AH, McLean TC. Advances in actino-mycete research: An ActinoBase review of 2019. Microbiology. 2020 Aug; 166(8):683–694. https://doi.org/10.1099/mic.0.000944
- Quince C, Walker AW, Simpson JT, Loman NJ, Segata N. Shotgun metagenomics, from sampling to analysis. Nat Biotechnol. 2017 Sep;35(9):833–844. https://doi.org/10.1038/nbt.3935
- R Core Team. A language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2016 [cited 2024 Aug 15]. Available from https://www.r-project.org
- Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K. Gut microbiota functions: Metabolism of nutrients and other food components. Eur J Nutr. 2018 Feb;57(1):1–24. https://doi.org/10.1007/s00394-017-1445-8
- Sakamoto Y, Mima K, Ishimoto T, Ogata Y, Imai K, Miyamoto Y, Akiyama T, Daitoku N, Hiyoshi Y, Iwatsuki M, et al. Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis. Cancer Sci. 2021 Nov;112(11): 4470–4477. https://doi.org/10.1111/cas.15126
- Sánchez-Alcoholado L, Ramos-Molina B, Otero A, Laborda-Illanes A, Ordóñez R, Medina JA, Gómez-Millán J, Queipo-Ortuño MI. The role of the gut microbiome in colorectal cancer development and therapy response. Cancers. 2020 May;12(6):1406. https://doi.org/10.3390/cancers12061406
- Sharma S, Hashmi M, Valentino III D. Actinomycosis. [Internet, Updated 2023 Aug 7]. Treasure Island (USA): StatPearls Publishing; 2023 [cited 2024 Aug 15]. Available from https://www.ncbi.nlm.nih.gov/books/NBK482151
- Sobhani I, Bergsten E, Couffin S, Amiot A, Nebbad B, Barau C, de’Angelis N, Rabot S, Canoui-Poitrine F, Mestivier D, et al. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc Natl Acad Sci USA. 2019 Nov;116(48): 24285–24295. https://doi.org/10.1073/pnas.1912129116
- Sobhani I, Tap J, Roudot-Thoraval F, Roperch JP, Letulle S, Langella P, Corthier G, Tran Van Nhieu J, Furet JP. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One. 2011 Jan; 6(1):e16393. https://doi.org/10.1371/journal.pone.0016393
- Song M, Chan AT. Environmental factors, gut microbiota, and colorectal cancer prevention. Clin Gastroenterol Hepatol. 2019 Jan; 17(2):275–289. https://doi.org/10.1016/j.cgh.2018.07.012
- Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E, Tett A, Huttenhower C, Segata N. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nat Methods. 2015 Oct;12(10):902–903. https://doi.org/10.1038/nmeth.3589
- Vivarelli S, Salemi R, Candido S, Falzone L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G, Libra M. Gut microbiota and cancer: From pathogenesis to therapy. Cancers. 2019 Jan;11(1):38. https://doi.org/10.3390/cancers11010038
- Wong SH, Yu J. Gut microbiota in colorectal cancer: Mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019 Nov;16(11):690–704. https://doi.org/10.1038/s41575-019-0209-8
- Wu SC, Rau CS, Liu HT, Kuo PJ, Chien PC, Hsieh TM, Tsai CH, Chuang JF, Huang CY, Hsieh HY, et al. Metagenome analysis as a tool to study bacterial infection associated with acute surgical abdomen. J Clin Med. 2018 Oct;7(10):346. https://doi.org/10.3390/jcm7100346
- Xu H, Liu M, Cao J, Li X, Fan D, Xia Y, Lu X, Li J, Ju D, Zhao H. The dynamic interplay between the gut microbiota and autoimmune diseases. J Immunol Res. 2019 Oct;2019:7546047. https://doi.org/10.1155/2019/7546047
- Xu Z, Lv Z, Chen F, Zhang Y, Xu Z, Huo J, Liu W, Yu S, Tuersun A, Zhao J, et al. Dysbiosis of human tumor microbiome and aberrant residence of Actinomyces in tumor-associated fibroblasts in youngonset colorectal cancer. Front Immunol. 2022 Sep;13:1008975. https://doi.org/10.3389/fimmu.2022.1008975
- Yoon H, Kim NE, Park J, Shin CM, Kim N, Lee DH, Park JY, Choi CH, Kim JG, Park YS. Analysis of the gut microbiome using extracellular vesicles in the urine of patients with colorectal cancer. Korean J Intern Med. 2023 Jan;38(1):27–38. https://doi.org/10.3904/kjim.2022.112
- Yoon Y, Kim G, Jeon BN, Fang S, Park H. Bifidobacterium strainspecific enhances the efficacy of cancer therapeutics in tumor-bearing mice. Cancers. 2021 Feb;13(5):957. https://doi.org/10.3390/cancers13050957
- Zhang W, Rhodes JS, Garg A, Takemoto JY, Qi X, Harihar S, Tom Chang CW, Moon KR, Zhou A. Label-free discrimination and quantitative analysis of oxidative stress induced cytotoxicity and potential protection of antioxidants using Raman micro-spectroscopy and machine learning. Anal Chim Acta. 2020a Sep;1128:221–230. https://doi.org/10.1016/j.aca.2020.06.074
- Zhang X, Chen BD, Zhao LD, Li H. The Gut microbiota: Emerging evidence in autoimmune diseases. Trends Mol Med. 2020b Sep; 26(9):862–873. https://doi.org/10.1016/j.molmed.2020.04.001